Related Experiment Video
Updated: Sep 3, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Concomitant acute limb ischemia and myocardial infarction: another challenge of COVID-19's hypercoagulability
Ouissal Aissaoui1, Salem Husam1, Anass Mounir1
1Department of Intensive Care and Anesthesiology, Ibn Rochd University Hospital, Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Morocco.
Insights
COVID-19 (SARS-CoV-2) can cause arterial thrombosis, leading to rare, simultaneous acute limb ischemia and myocardial infarction. This case highlights hypercoagulability challenges in managing severe COVID-19 complications.
Area of Science:
- Cardiology
- Infectious Diseases
- Vascular Surgery
Background:
- COVID-19 (SARS-CoV-2) is linked to thromboembolic events, with venous thrombosis being more documented.
- Arterial thrombosis is a less common but severe complication of COVID-19.
Observation:
- A 77-year-old COVID-19 patient presented with acute lower limb ischemia and myocardial infarction.
- This dual arterial event in a COVID-19 patient is extremely rare and indicative of hypercoagulability.
Findings:
- The patient underwent coronary angiography with stent placement, followed by thrombectomy for limb ischemia.
- Despite interventions, the patient experienced persistent cardiogenic shock, reperfusion syndrome, and multiorgan failure.
Implications:
- This case underscores the significant vascular risks associated with COVID-19, presenting a challenge for clinicians.
- Effective management strategies for concomitant arterial thrombosis and cardiac events in COVID-19 patients require further investigation.
Abstract:
The COVID-19, actual pandemic due to SARS COV 2 is associated with numerous thromboembolic complications. Although venous thrombosis including pulmonary embolisms have been widely described, arterial localization seems rarely reported. Acute limb ischemia and myocardial infarction are two major consequences of arterial thrombosis and their concomitant occurrence among COVID-19 patients is extremely rare. It is an evident aspect of hypercoagulability and a real challenge to physicians. We herein describe the management of a 77 years old COVID-19 patient presenting an acute lower limb ischemia with concomitant myocardial infarction. He underwent coronary angiography with subsequent stent placement then was transferred to the operating room where a thrombectomy was performed. The outcome was poor as the cardiogenic shock persisted in addition to a reperfusion syndrome with multiorgan failure.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Coronary Artery Disease III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Myocarditis I: Introduction